Novo Holdings to sell 7.8% stake in UK's Convatec, bookrunner says

Novo Holdings, which controls obesity drugmaker Novo Nordisk , will sell 155 million shares, or about 7.8% of its stake, in British medical products maker Convatec Group , a bookrunner for the offerin... ...